Analysts Set GoodRx Holdings, Inc. (NASDAQ:GDRX) PT at $8.18

Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) have earned a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $8.18.

GDRX has been the subject of several analyst reports. KeyCorp cut their target price on shares of GoodRx from $7.00 to $6.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Wells Fargo & Company lowered their target price on shares of GoodRx from $9.00 to $8.00 and set an “overweight” rating for the company in a research note on Friday, February 28th. Citigroup cut their price target on GoodRx from $7.00 to $6.25 and set a “buy” rating for the company in a report on Friday, January 10th. Finally, Morgan Stanley decreased their price objective on GoodRx from $7.00 to $6.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. National Bank of Canada FI increased its position in shares of GoodRx by 34.9% in the fourth quarter. National Bank of Canada FI now owns 8,308 shares of the company’s stock worth $39,000 after acquiring an additional 2,151 shares in the last quarter. EP Wealth Advisors LLC acquired a new stake in GoodRx in the 3rd quarter valued at $73,000. RPO LLC purchased a new position in GoodRx in the fourth quarter valued at about $52,000. Versor Investments LP acquired a new position in shares of GoodRx during the fourth quarter worth about $54,000. Finally, Verus Capital Partners LLC purchased a new stake in shares of GoodRx in the fourth quarter worth about $55,000. 63.77% of the stock is owned by institutional investors and hedge funds.

GoodRx Stock Performance

GoodRx stock opened at $4.12 on Tuesday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.48 and a current ratio of 5.48. GoodRx has a fifty-two week low of $4.00 and a fifty-two week high of $9.26. The stock has a fifty day moving average of $4.73 and a two-hundred day moving average of $5.18. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -137.33, a PEG ratio of 2.46 and a beta of 1.25.

About GoodRx

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.